Last reviewed · How we verify
NCT04287465
Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode
trial in Parkinson Disease in 30 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | Hospital District of Helsinki and Uusimaa |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 August 2018 |
| Primary completion | 1 December 2024 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Finland |
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Deep Brain Stimulation — all drugs for Deep Brain Stimulation →
Sponsor
Hospital District of Helsinki and Uusimaa
Who can join
Under 80, any sex, with Parkinson Disease or Deep Brain Stimulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the clinical outcome of patients with Parkinson's disease (PD) treated with directional deep brain (dDBS) stimulation undergoing subthalamic deep brain stimulation operation (STN-DBS) under general anesthesia versus local anesthesia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04287465
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Hospital District of Helsinki and Uusimaa trials
Trials by the same sponsor.
- NCT05632432 — Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery · NA · recruiting
- NCT06095245 — The Outcome of Subthalamic Deep Brain Stimulation in Advanced Parkinson's Disease and Morphometry · unknown
- NCT05795127 — Risk for Reoperation After First MTP Joint Arthrodesis · active not recruiting
- NCT05394688 — Directional Deep Brain Stimulation With Patients With Advanced Parkinson's Disease · completed
- NCT04590313 — Efficacy of First MTPJ Arthrodesis as a Treatment in Hallux Rigidus · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04287465 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital District of Helsinki and Uusimaa
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04287465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing